Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders

@article{2016PracticeBN,
  title={Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders},
  author={},
  journal={Obstetrics \& Gynecology},
  year={2016},
  volume={127},
  pages={e108–e122}
}
  • Published 1 May 2016
  • Medicine
  • Obstetrics & Gynecology
Prenatal genetic diagnostic testing is intended to determine, with as much certainty as possible, whether a specific genetic disorder or condition is present in the fetus. In contrast, prenatal genetic screening is designed to assess whether a patient is at increased risk of having a fetus affected by a genetic disorder. Originally, prenatal genetic testing focused primarily on Down syndrome (trisomy 21), but now it is able to detect a broad range of genetic disorders. Although it is necessary… Expand
Screening for Fetal Chromosomal Abnormalities.
TLDR
This Practice Bulletin has been revised to further clarify methods of screening for fetal chromosomal abnormalities, including expanded information regarding the use of cell-free DNA in all patients regardless of maternal age or baseline risk, and to add guidance related to patient counseling. Expand
Genetic testing for unexplained perinatal disorders
TLDR
Perinatal disorders of unknown cause, with nonspecific presentations, are often caused by genetic diseases best diagnosed by ES or GS, and having a specific genetic diagnosis provides significant clinical utility. Expand
Genomic Testing for Prenatal Clinical Evaluation of Congenital Anomalies
TLDR
An overview of the conventional genetic diagnostic approach and the use of new genomic technologies in the diagnostic algorithm of prenatally detected congenital anomalies are discussed. Expand
Beyond the Brochure: Innovations in Clinical Counseling Practices for Prenatal Genetic Testing Options
TLDR
This article will arm providers with the knowledge needed to educate women about currently available prenatal genetic screening and diagnostic tests along with guidance on the essential elements and importance of genetic counseling. Expand
Women should decide which conditions matter.
TLDR
Among women identified as screen positive, cell-free (cf)DNA has been added recently as a secondary, noninvasive screening option, before the consideration of invasive diagnostic testing (eg, amniocentesis and karyotype), with the anticipation of lower costs in the future. Expand
Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities
TLDR
Current guidelines are reviewed and developed a Korean CPG on invasive diagnostic testing for fetal chromosome abnormalities according to the adaptation process and the risk of fetal loss due to invasive prenatal diagnostic testing is higher in twin pregnancies than in singleton pregnancies. Expand
Exome Sequencing and Its Emerging Role in Prenatal Genetic Diagnosis
TLDR
Exome sequencing may be a useful prenatal genetic diagnostic tool in cases with ultrasound anomalies with previously normal chromosomal microarray and/or karyotype and may become more widely used in prenatal genetic diagnosis as more data become available, technology improves, and costs fall. Expand
Where have all the trisomies gone?
TLDR
Among women identified as screen positive, cell-free (cf)DNA has been added recently as a secondary, noninvasive screening option, before the consideration of invasive diagnostic testing (eg, amniocentesis and karyotype). Expand
Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder
TLDR
Prenatal exome sequencing is a useful diagnostic tool when fetal structural anomalies suggest a genetic etiology, but other standard prenatal genetic tests did not provide a diagnosis. Expand
Utility of expanded carrier screening in pregnancies with ultrasound abnormalities.
TLDR
This study demonstrates limited but potential utility for expanded carrier screening to determine the underlying etiology of congenital anomalies in infants evaluated postnatally by a medical geneticist. Expand
...
1
2
3
4
5
...